Ş. N. Kalın Et Al. , "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells," Chemico-Biological Interactions , vol.361, 2022
Kalın, Ş. N. Et Al. 2022. Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells. Chemico-Biological Interactions , vol.361 .
Kalın, Ş. N., Altay, A., & Budak, H., (2022). Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells. Chemico-Biological Interactions , vol.361.
Kalın, Şeyda, AHMET ALTAY, And Harun Budak. "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells," Chemico-Biological Interactions , vol.361, 2022
Kalın, Şeyda N. Et Al. "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells." Chemico-Biological Interactions , vol.361, 2022
Kalın, Ş. N. Altay, A. And Budak, H. (2022) . "Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells." Chemico-Biological Interactions , vol.361.
@article{article, author={Şeyda Nur Kalın Et Al. }, title={Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells}, journal={Chemico-Biological Interactions}, year=2022}